1515 — China Resources Medical Holdings Income Statement
0.000.00%
Last trade - 00:00- HK$4.69bn
- HK$6.72bn
- CNY9.85bn
- 69
- 80
- 68
- 86
Annual income statement for China Resources Medical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,751 | 4,447 | 7,901 | 10,108 | 9,855 |
| Cost of Revenue | |||||
| Gross Profit | 637 | 934 | 1,306 | 1,906 | 1,810 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,342 | 4,237 | 7,495 | 9,574 | 9,039 |
| Operating Profit | 408 | 210 | 406 | 534 | 815 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 418 | 270 | 423 | 493 | 839 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 320 | 426 | 328 | 328 | 672 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 310 | 418 | 266 | 258 | 566 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 310 | 418 | 266 | 258 | 566 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.241 | 0.446 | 0.291 | 0.458 | 0.48 |
| Dividends per Share |